Wait til the 4C is released, it will show just how many more capital raisings will be necessary to stay afloat. Directors are not buying at this price cause they know dilution is coming big time
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025